BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11445074)

  • 1. The specificity of lysosomal tripeptidyl peptidase-I determined by its action on angiotensin-II analogues.
    Warburton MJ; Bernardini F
    FEBS Lett; 2001 Jul; 500(3):145-8. PubMed ID: 11445074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
    Vines DJ; Warburton MJ
    FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
    Ezaki J; Takeda-Ezaki M; Kominami E
    J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substrate range of tripeptidyl-peptidase I.
    Bernardini F; Warburton MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates.
    Tian Y; Sohar I; Taylor JW; Lobel P
    J Biol Chem; 2006 Mar; 281(10):6559-72. PubMed ID: 16339154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
    Kopan S; Sivasubramaniam U; Warburton MJ
    Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
    Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
    Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
    Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA
    Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
    Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.
    Warburton MJ; Bernardini F
    J Inherit Metab Dis; 2000 Mar; 23(2):145-54. PubMed ID: 10801056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tripeptidyl-peptidase I--distribution, biogenesis, and mechanisms of activation].
    Gołabek AA
    Postepy Biochem; 2006; 52(1):16-23. PubMed ID: 16869297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of catalytic properties of tripeptidyl peptidase I (TTP-I), a serine carboxyl lysosomal protease, and its detection in tissue extracts using selective FRET peptide substrate.
    Kondo MY; Gouvea IE; Okamoto DN; Santos JA; Souccar C; Oda K; Juliano L; Juliano MA
    Peptides; 2016 Feb; 76():80-6. PubMed ID: 26775801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripeptidyl peptidases: enzymes that count.
    Tomkinson B
    Trends Biochem Sci; 1999 Sep; 24(9):355-9. PubMed ID: 10470035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific substrate for CLN2 protease/tripeptidyl-peptidase I assay.
    Junaid MA; Brooks SS; Pullarkat RK
    Eur J Paediatr Neurol; 2001; 5 Suppl A():63-8. PubMed ID: 11589010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
    Rawlings ND; Barrett AJ
    Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of tripeptidyl peptidase I from Dictyostelium discoideum.
    Krimper RP; Jones TH
    Biochem Mol Biol Int; 1999 Jun; 47(6):1079-88. PubMed ID: 10410254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.
    Golabek AA; Dolzhanskaya N; Walus M; Wisniewski KE; Kida E
    J Biol Chem; 2008 Jun; 283(24):16497-504. PubMed ID: 18411270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
    Golabek AA; Kida E; Walus M; Wujek P; Mehta P; Wisniewski KE
    J Biol Chem; 2003 Feb; 278(9):7135-45. PubMed ID: 12488460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.